FI46389C - Menetelmä terapeuttisesti arvokkaiden 1-beetta-d-ribofuranosyyli- ja 1 -(2-desoksi-beetta-d-ribofuranosyyli)-5-atsasytosiinien valmistamiseks i. - Google Patents
Menetelmä terapeuttisesti arvokkaiden 1-beetta-d-ribofuranosyyli- ja 1 -(2-desoksi-beetta-d-ribofuranosyyli)-5-atsasytosiinien valmistamiseks i.Info
- Publication number
- FI46389C FI46389C FI642632A FI263264A FI46389C FI 46389 C FI46389 C FI 46389C FI 642632 A FI642632 A FI 642632A FI 263264 A FI263264 A FI 263264A FI 46389 C FI46389 C FI 46389C
- Authority
- FI
- Finland
- Prior art keywords
- beta
- ribofanosyl
- azacytosines
- ribofuranosyl
- deoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS709363 | 1963-12-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
FI46389B FI46389B (fi) | 1972-11-30 |
FI46389C true FI46389C (fi) | 1973-03-12 |
Family
ID=5419399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI642632A FI46389C (fi) | 1963-12-22 | 1964-12-12 | Menetelmä terapeuttisesti arvokkaiden 1-beetta-d-ribofuranosyyli- ja 1 -(2-desoksi-beetta-d-ribofuranosyyli)-5-atsasytosiinien valmistamiseks i. |
Country Status (13)
Country | Link |
---|---|
US (1) | US3350388A (fi) |
AT (1) | AT252458B (fi) |
BE (1) | BE657451A (fi) |
BR (1) | BR6465569D0 (fi) |
CH (1) | CH479595A (fi) |
DE (1) | DE1245384B (fi) |
DK (1) | DK108500C (fi) |
ES (1) | ES307376A1 (fi) |
FI (1) | FI46389C (fi) |
FR (1) | FR1450440A (fi) |
GB (1) | GB1050899A (fi) |
IT (1) | IT1043755B (fi) |
NL (1) | NL6414959A (fi) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1030970A (en) * | 1964-05-15 | 1966-05-25 | Inst Mikrobiologii Im Akad D K | Method for the preparation of 2', 3', 5'-tri-o-acyl-6-azacytidines |
DE2012888C3 (de) * | 1970-03-14 | 1981-04-02 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden |
US6943249B2 (en) | 2003-03-17 | 2005-09-13 | Ash Stevens, Inc. | Methods for isolating crystalline Form I of 5-azacytidine |
US6887855B2 (en) | 2003-03-17 | 2005-05-03 | Pharmion Corporation | Forms of 5-azacytidine |
US7038038B2 (en) * | 2003-03-17 | 2006-05-02 | Pharmion Corporation | Synthesis of 5-azacytidine |
US20060014949A1 (en) * | 2004-07-13 | 2006-01-19 | Supergen Inc. | Compositions and formulations of decitabine polymorphs and methods of use thereof |
WO2009042064A2 (en) | 2007-09-21 | 2009-04-02 | Nektar Therapeutics Al, Corporation | Oligomer-nucleoside phosphate conjugates |
EP2205073A4 (en) * | 2007-09-26 | 2013-03-06 | Sinai School Medicine | AZACYTIDINE ANALOGS AND USES THEREOF |
NZ623495A (en) | 2008-05-15 | 2015-08-28 | Celgene Corp | Oral formulations of cytidine analogs and methods of use thereof |
EP2321302B1 (en) | 2008-08-01 | 2014-10-29 | Dr. Reddy's Laboratories Ltd. | Azacitidine process and polymorphs |
EP2318423B1 (en) * | 2008-08-08 | 2014-05-07 | ScinoPharm Taiwan, Ltd. | Process for making 5-azacytosine nucleosides and their derivatives |
CA2755976C (en) * | 2009-03-23 | 2020-04-07 | Ambit Biosciences Corporation | Methods of treatment using combination therapy |
IT1399195B1 (it) | 2010-03-30 | 2013-04-11 | Chemi Spa | Processo per la sintesi di azacitidina e decitabina |
CN103619864A (zh) | 2011-03-31 | 2014-03-05 | 细胞基因国际有限公司 | 5-氮杂胞苷的合成 |
JP6042527B2 (ja) | 2012-04-04 | 2016-12-14 | ハロザイム インコーポレイテッド | 抗ヒアルロナン剤と腫瘍標的タキサンの組み合わせ治療 |
CN108239128B (zh) | 2016-12-23 | 2019-03-29 | 江苏奥赛康药业股份有限公司 | β-核苷类化合物的制备方法 |
WO2019222435A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
-
0
- GB GB1050899D patent/GB1050899A/en active Active
-
1964
- 1964-12-08 DE DEC34587A patent/DE1245384B/de active Pending
- 1964-12-09 CH CH1590864A patent/CH479595A/de not_active IP Right Cessation
- 1964-12-10 AT AT1047164A patent/AT252458B/de active
- 1964-12-12 FI FI642632A patent/FI46389C/fi active
- 1964-12-14 US US418273A patent/US3350388A/en not_active Expired - Lifetime
- 1964-12-18 DK DK620664AA patent/DK108500C/da active
- 1964-12-19 IT IT27006/64A patent/IT1043755B/it active
- 1964-12-21 ES ES0307376A patent/ES307376A1/es not_active Expired
- 1964-12-22 FR FR999626A patent/FR1450440A/fr not_active Expired
- 1964-12-22 BE BE657451D patent/BE657451A/xx unknown
- 1964-12-22 NL NL6414959A patent/NL6414959A/xx unknown
- 1964-12-22 BR BR165569/64A patent/BR6465569D0/pt unknown
Also Published As
Publication number | Publication date |
---|---|
CH479595A (de) | 1969-10-15 |
DK108500C (da) | 1967-12-27 |
IT1043755B (it) | 1980-02-29 |
NL6414959A (fi) | 1965-06-23 |
BR6465569D0 (pt) | 1973-08-02 |
ES307376A1 (es) | 1965-05-01 |
DE1245384B (de) | 1967-07-27 |
US3350388A (en) | 1967-10-31 |
FI46389B (fi) | 1972-11-30 |
BE657451A (fi) | 1965-04-16 |
GB1050899A (fi) | |
FR1450440A (fr) | 1966-06-24 |
AT252458B (de) | 1967-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI47364C (fi) | Menetelmä terapeuttisesti arvokkaiden 3-indolyyli-alifaattinen-happoyh disteiden valmistamiseksi. | |
FI46389C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-beetta-d-ribofuranosyyli- ja 1 -(2-desoksi-beetta-d-ribofuranosyyli)-5-atsasytosiinien valmistamiseks i. | |
FI45970C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. | |
SE300618B (sv) | Förfarande för framställning av N-fenylpropyl- N1 -fenylpiperaziner | |
FI45662C (fi) | Menetelmä fysiologisesti arvokkaiden penisilliinien valmistamiseksi. | |
DK115400B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner. | |
FI45180C (fi) | Menetelmä terapeuttisesti arvokkaiden sulfonanilidien valmistamiseksi. | |
FI45041C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi. | |
DK121708B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater. | |
FI44622C (fi) | Menetelmä terapeuttisesti arvokkaiden substituoitujen naftaleenijohdan naisten valmistamiseksi. | |
CH447761A (de) | Emaillierverfahren | |
FI46388C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-beetta-d-ribofuranosyyli- ja 1 -(2-desoksi-beetta-d-ribofuranosyyli-5-atsasytosiinien valmistamiseksi . | |
FI47092C (fi) | Menetelmä terapeuttisesti arvokkaiden sekasubstituoitujen 1-fenoksi-3- alkyyliaminopropanolien-(2) valmistamiseksi. | |
FI47097C (fi) | Menetelmä terapeuttisesti vaikuttavan 1-p-klooribentsoyyli-2-metyyli-5 -metoksi-3-indolyylietikkahapon valmistamiseksi. | |
NL141863B (nl) | Werkwijze ter bereiding van acrylonitrile. | |
FI49289C (fi) | Menetelmä uusien terapeuttisesti arvokkaiden 1-(2-etinyylifenoksi)-2-h ydroksi-3-alkyyliaminopropaanien valmistamiseksi. | |
FI47358C (fi) | Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi. | |
FI43994C (fi) | Menetelmä uusien terapeuttisesti vaikuttavien 1,2-diaryyli-4-alkyyli-3,5-diokso-pyratsolidiinien valmistamiseksi | |
FI45954C (fi) | Menetelmä terapeuttisesti vaikuttavien bentseenisulfonyylivirtsa-ainei den valmistamiseksi. | |
FI36453A (fi) | Förfarande för framställning av sulfamylantranilsyra | |
FI34011A (fi) | Förfarande för framställning av hydrazider | |
FI34010A (fi) | Förfarande för framställning av hydrazider | |
FI37662A (fi) | Förfarande för framställning av 2,3-dihydroxipyrazin | |
FI37500A (fi) | Sätt för framställning av 3-hydroxi-11,20-diketo-16beeta-alkyl-16-pregnener | |
AU275440B2 (en) | Fluoropyrimidines and process forthe manufacture thereof |